dr. budd discusses prior trastuzumab and paclitaxel regimens
Published 11 years ago • 232 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
1:09
dr. budd discusses paclitaxel regimens in breast cancer
-
4:34
paclitaxel with pertuzumab plus trastuzumab in metastatic breast cancer
-
6:11
which chemotherapy with adjuvant trastuzumab and pertuzumab?
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
1:45
nab-paclitaxel as neoajuvant therapy for breast cancer
-
6:09
nab-paclitaxel in metastatic breast cancer
-
1:24
dr. verma on treatments in the neoadjuvant setting of her2 breast cancer
-
4:26
dr. sara tolaney on adjuvant t-dm1 vs paclitaxel and trastuzumab for stage i her2 breast cancer
-
1:54
nab-paclitaxel as neoadjuvant therapy for breast cancer
-
1:58
dr. seidman on paclitaxel schedules as adjuvant therapy for breast cancer
-
1:45
dr. piccart on the success of trastuzumab
-
1:22
dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
-
6:17
sara tolaney, sabcs 2022: adjuvant paclitaxel and trastuzumab for node-negative her2 breast cancer
-
1:06
dr. mark pegram on combining trastuzumab and pertuzumab
-
5:09
trastuzumab deruxtecan shows benefit across her2 metastatic breast cancer subgroups
-
7:24
sabcs 2011: cleopatra trial, efficacy and safety of pertuzumab, trastuzumab, docetaxel
-
3:51
study comparing margetuximab combinations to trastuzumab combinations in her2-positive breast cancer
-
0:51
dr. jhaveri on the use of trastuzumab biosimilars in breast cancer
-
1:06
dr. tripathy on determining the best her2 targeted therapy